Welcome to our dedicated page for Dupont De Nemours news (Ticker: DD), a resource for investors and traders seeking the latest updates and insights on Dupont De Nemours stock.
DuPont de Nemours, Inc. reports recurring developments across its specialty materials and advanced solutions businesses serving healthcare, water, construction and industrial markets. Company updates include product introductions such as DuPont Water Solutions digital tools for reverse osmosis operations, Corian® Design surface materials, and Liveo™ components for pharmaceutical and biopharmaceutical processing.
DuPont news also covers R&D and digital innovation initiatives, including AI-enabled laboratory workflows and customer-facing analytics, along with operating and financial results, regular common-stock dividends, shareholder voting matters, capital-structure disclosures and governance changes.
DuPont (NYSE: DD) launched DuPont™ AmberLite™ FPA57 resin on Jan. 28, 2026, a weak base anion resin for organic acid purification.
The resin offers 5–10% longer cycle times, higher total exchange capacity, greater fouling resistance, the same particle size/hydraulics as FPA55, and aims to lower regenerant chemical use and wastewater.
DuPont (NYSE: DD) is accepting applications for the 3rd annual Tyvek® Sustainable Healthcare Packaging Awards, recognizing healthcare packaging initiatives that use Tyvek® to advance sustainability. The program is open to medical device and pharmaceutical manufacturers, sterile packagers, healthcare facilities, universities, material recovery facilities and other healthcare companies. Entries must describe initiatives implemented within the last 18 months and demonstrate measurable sustainability achievements.
Applications are available at www.Tyvek.com/HCAwards and the submission window closes on May 22, 2026. Winners will be announced at DuPont's Medical Packaging Conference in Fall 2026 in North America.
DuPont (NYSE: DD) will release fourth quarter and full year 2025 results at 6:00 a.m. ET on Tuesday, February 10, 2026. The company will host a conference call at 8:00 a.m. ET the same day. The event will be webcast live on DuPont's investor relations webpage, with a replay, the earnings release, and supporting materials posted after the call. Dial-in is 888-440-4172 (U.S. toll-free) or +1-646-960-0673 with conference ID 5994046.
DuPont (NYSE: DD) announced on January 20, 2026 the appointment of D.G. Macpherson to its Board of Directors, effective immediately. Mr. Macpherson currently serves as Chairman and Chief Executive Officer of W.W. Grainger, where he is in his tenth year as CEO and leads global strategy and operations.
His background includes roles as Grainger chief operating officer and group president for global supply chain and international, prior experience as a partner and managing director at Boston Consulting Group, a bachelor’s from Stanford, and an MBA from Kellogg School of Management.
DuPont (NYSE:DD) announced on December 5, 2025 that Kevlar® EXO™ is expanding from soft armor into hard armor applications, including helmets and ballistic plate inserts.
The material will serve a structural reinforcement role within composite hard armor to improve impact resistance, energy absorption, limit crack propagation, and strengthen structural integrity. Kevlar EXO is already being integrated into plates for TYR Tactical and DuPont cites potential broader uses from fuel bladders to space-structure components due to its strength-to-weight advantages.
DuPont (NYSE:DD) announced on Dec 5, 2025 that Kevlar EXO is expanding from soft armor into hard armor applications, including helmets and ballistic plate inserts. The fiber will serve as a structural reinforcement within composite plates, improving impact resistance, energy absorption, crack propagation control and structural integrity.
Kevlar EXO is already being integrated into plates for TYR Tactical and is being positioned for broader composite uses from fuel bladders to aerospace structures.
DuPont (NYSE: DD) announced early results of its tender offer to purchase up to $739,256,000 aggregate principal amount of its 5.419% notes due 2048. As of the early tender date (5:00 p.m. ET on Nov 17, 2025), $936,618,000 of 2048 notes were validly tendered, triggering a proration factor of 78.9627%. DuPont will accept $739,256,000 on a prorated basis and will make payment on the early settlement date of Nov 19, 2025. Consideration is $1,000 per $1,000 principal plus accrued interest. The tender offer remains open until Dec 3, 2025 unless extended; after expected redemptions and repayments, DuPont expects to have repaid approximately $4.0 billion of senior notes to reach its targeted post-separation capital structure.
DuPont (NYSE: DD) broke ground on a new MOLYKOTE® specialty lubricants manufacturing plant in Zhangjiagang, Jiangsu Province, China, on Nov 18, 2025. The facility is being built at the Yangtze River International Chemical Industrial Park in the Zhangjiagang Free Trade Zone and is expected to be operational by early 2027.
The project aims to expand global capacity, shorten lead times, improve agility, and strengthen local R&D and customer collaboration to address demand across transportation, industrial, energy, and electronics markets in China and Asia-Pacific.
DuPont (NYSE: DD) reported 3Q 2025 results and announced capital returns on Nov 6, 2025. Net sales were $3.07B, up 7% (organic +6%). Operating EBITDA was $840M and management raised full‑year 2025 operating EBITDA guidance to ~$1.6B. GAAP income from continuing operations was $308M and GAAP EPS was $0.70; adjusted EPS was $1.09. Cash from operations was $591M and transaction‑adjusted free cash flow was $576M (126% conversion). The board approved a $2B buyback, a $500M ASR and a quarterly dividend of $0.20 per share payable Dec 15, 2025.
DuPont (NYSE:DD) on November 4, 2025 introduced Tyvek® APX™, a new disposable chemical garment fabric unveiled at A+A 2025 in Dusseldorf designed to boost breathability without reducing protection or durability.
DuPont cites independent physiological testing by Empa that demonstrated enhanced breathability versus traditional chemical-protective garments, plus global customer wear trials with almost 300 participants across varied temperatures, humidity and activity levels that showed a clear preference for Tyvek APX.